Prospera Financial Services’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,331	Closed	-$215K	–	1235
2024 Q4	$215K	Buy	5,331 +624	+13%	+$25.1K	0.01%	1061
2024 Q3	$298K	Buy	+4,707	New	+$298K	0.01%	923
2024 Q2	–	Sell	-3,565	Closed	-$292K	–	1188
2024 Q1	$292K	Buy	+3,565	New	+$292K	0.01%	910